<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">467Tcxps4cnwspQ7hr8x3zg</article-id>
      <article-id pub-id-type="other">00010</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2009000700010</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(09)09300110</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2009000700010</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ecocardiograma sob estresse com dobutamina em pacientes assintom&#225;ticos com regurgita&#231;&#227;o a&#243;rtica</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Barbosa</surname>
            <given-names>Marcia M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freire</surname>
            <given-names>Claudia M. V.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fenelon</surname>
            <given-names>L&#250;cia M. A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Esteves</surname>
            <given-names>William A. M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reis</surname>
            <given-names>Gilmar</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nunes</surname>
            <given-names>Maria do Carmo P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">Minas Gerais</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Belo Horizonte</named-content>
          <named-content content-type="state">MG</named-content>
        </addr-line>
        <institution content-type="orgname">Ecocenter</institution>
        <institution content-type="orgdiv1">Hospital Socor </institution>
        <country country="BR">Brasil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>07</month>
        <year>2009</year>
      </pub-date>
      <volume>93</volume>
      <issue>1</issue>
      <fpage>53</fpage>
      <lpage>58</lpage>
      <history>
        <date date-type="rev-recd">
          <day>07</day>
          <month>04</month>
          <year>2008</year>
        </date>
        <date date-type="received">
          <day>30</day>
          <month>01</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>04</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A reserva contr&#225;til diminu&#237;da pode j&#225; estar presente em pacientes portadores de regurgita&#231;&#227;o a&#243;rtica, assintom&#225;ticos com fra&#231;&#227;o de eje&#231;&#227;o (FE) normal, indicando a necessidade de avalia&#231;&#245;es frequentes e acuradas da fun&#231;&#227;o ventricular esquerda para detectar disfun&#231;&#227;o sist&#243;lica incipiente. OBJETIVO: Analisar se incrementos na FE em doses baixas de dobutamina podem predizer cirugia e/ou morte em pacientes com regurgita&#231;&#227;o a&#243;rtica. M&#201;TODOS: Eco de estresse com dobutamina foi realizado em 24 pacientes portadores de regurgita&#231;&#227;o a&#243;rtica para verificar se incrementos da FE em doses baixas de dobutamina seriam capazes de predizer a necessidade de cirurgia e/ou morte nesse grupo de pacientes. RESULTADOS: A idade m&#233;dia foi de 37,8&#177;16,8 anos, e 16 (66%) eram homens. A FE aumentou de um valor basal m&#233;dio de 62,3&#177;7,9% para 71,5&#177;10,5%, na dose de 20 &#181;g/kg/min de dobutamina (p &lt; 0,001). Os pacientes foram acompanhados por 36,6&#177;20,1 meses: dois pacientes morreram (um de morte cardiovascular) e cinco foram submetidos &#224; cirurgia card&#237;aca. A FE basal se correlacionou com cirurgia e morte no seguimento de pacientes. CONCLUS&#195;O: A FE basal se correlacionou com cirurgia ou morte no seguimento de pacientes jovens com regurgita&#231;&#227;o a&#243;rtica. Por&#233;m, o incremento percentual na FE com dose baixa de dobutamina n&#227;o foi capaz de predizer eventos nesses pacientes.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Ecocardiografia sob estresse</kwd>
        <kwd>dobutamina</kwd>
        <kwd>pacientes</kwd>
        <kwd>insufici&#234;ncia da valva a&#243;rtica</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>13</day>
        <month>10</month>
        <year>2009</year>
      </pub-date>
    </article-meta>
  </front>
  <body><p>ARTIGO ORIGINAL </p><p> VALVOPATIAS</p><p><bold>Ecocardiograma sob estresse com dobutamina em pacientes assintom&#225;ticos com regurgita&#231;&#227;o a&#243;rtica</bold></p><p><bold>Marcia M. Barbosa<sup>I</sup>; Claudia M. V. Freire<sup>I, II</sup>; L&#250;cia M. A. Fenelon<sup>II</sup>; William A. M. Esteves<sup>I</sup>; Gilmar Reis<sup>II</sup>; Maria do Carmo P. Nunes<sup>I, II</sup></bold></p><sup>I</sup>Universidade Federal de Minas Gerais <p><sup>II</sup>Ecocenter, Hospital Socor, Belo Horizonte, MG - Brasil </p><p><xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref></p><p><bold>RESUMO</bold></p><bold>FUNDAMENTO: </bold> A reserva contr&#225;til diminu&#237;da pode j&#225; estar presente em pacientes portadores de regurgita&#231;&#227;o a&#243;rtica, assintom&#225;ticos com fra&#231;&#227;o de eje&#231;&#227;o (FE) normal, indicando a necessidade de avalia&#231;&#245;es frequentes e acuradas da fun&#231;&#227;o ventricular esquerda para detectar disfun&#231;&#227;o sist&#243;lica incipiente. <p content-type="break"><bold>OBJETIVO:</bold> Analisar se incrementos na FE em doses baixas de dobutamina podem predizer cirugia e/ou morte em pacientes com regurgita&#231;&#227;o a&#243;rtica. </p><p content-type="break"><bold>M&#201;TODOS:</bold> Eco de estresse com dobutamina foi realizado em 24 pacientes portadores de regurgita&#231;&#227;o a&#243;rtica para verificar se incrementos da FE em doses baixas de dobutamina seriam capazes de predizer a necessidade de cirurgia e/ou morte nesse grupo de pacientes. </p><p content-type="break"><bold>RESULTADOS: </bold> A idade m&#233;dia foi de 37,8&#177;16,8 anos, e 16 (66%) eram homens. A FE aumentou de um valor basal m&#233;dio de 62,3&#177;7,9% para 71,5&#177;10,5%, na dose de 20 &#181;g/kg/min de dobutamina (p &lt; 0,001). Os pacientes foram acompanhados por 36,6&#177;20,1 meses: dois pacientes morreram (um de morte cardiovascular) e cinco foram submetidos &#224; cirurgia card&#237;aca. A FE basal se correlacionou com cirurgia e morte no seguimento de pacientes. </p><p content-type="break"><bold>CONCLUS&#195;O:</bold> A FE basal se correlacionou com cirurgia ou morte no seguimento de pacientes jovens com regurgita&#231;&#227;o a&#243;rtica. Por&#233;m, o incremento percentual na FE com dose baixa de dobutamina n&#227;o foi capaz de predizer eventos nesses pacientes.  </p><p><bold>Palavras-chave: </bold> Ecocardiografia sob estresse, dobutamina, pacientes, insufici&#234;ncia da valva a&#243;rtica.</p>     <p><bold>Introdu&#231;&#227;o</bold></p> <p>O momento cir&#250;rgico da troca valvar a&#243;rtica em pacientes com regurgita&#231;&#227;o a&#243;rtica importante &#233; dif&#237;cil de definir na aus&#234;ncia de sintomas. Estudos pr&#233;vios sugerem que pacientes assintom&#225;ticos t&#234;m um bom progn&#243;stico<sup>1,2</sup>. Contudo, a evolu&#231;&#227;o dos pacientes pouco sintom&#225;ticos ou do subgrupo assintom&#225;tico, mas que podem estar expostos a um risco elevado de disfun&#231;&#227;o ventricular, n&#227;o est&#225; estabelecida. &#201; necess&#225;rio que a troca valvar precoce seja bem avaliada, j&#225; que a hist&#243;ria natural da regurgita&#231;&#227;o a&#243;rtica &#233;, em geral, benigna e a taxa de mortalidade cir&#250;rgica da troca valvar &#233; pequena, mas n&#227;o desprez&#237;vel. Al&#233;m disso, existe incerteza quanto &#224; fun&#231;&#227;o em longo prazo das pr&#243;teses valvares.</p> <p>V&#225;rios estudos t&#234;m demonstrado que mesmo pacientes assintom&#225;ticos com regurgita&#231;&#227;o a&#243;rtica e fun&#231;&#227;o ventricular esquerda normal podem demonstrar uma resposta anormal da fun&#231;&#227;o ventricular ao esfor&#231;o. Disfun&#231;&#227;o ventricular esquerda durante o esfor&#231;o &#233; um preditor importante do progn&#243;stico da regurgita&#231;&#227;o a&#243;rtica cr&#244;nica. Contudo, esta n&#227;o &#233; f&#225;cil de definir, nem o seu mecanismo est&#225; completamente estabelecido, parecendo ser multifatorial, n&#227;o indicando necessariamente disfun&#231;&#227;o de ventr&#237;culo esquerdo (VE). A ventriculografia radionucl&#233;ica &#233; frequentemente realizada em pacientes assintom&#225;ticos para detectar disfun&#231;&#227;o ventricular esquerda precoce, embora essa modalidade de exame seja classe IIB nas diretrizes americanas<sup>3</sup>. A ecocardiografia de estresse tem sido intensamente utilizada no diagn&#243;stico da doen&#231;a coronariana e ocasionalmente na evolu&#231;&#227;o de casos selecionados de doen&#231;as valvares, como estenose a&#243;rtica<sup>4-6</sup>, estenose mitral<sup>7,8</sup> e regurgita&#231;&#227;o a&#243;rtica<sup>9-11</sup>.</p> <p>Como a ecocardiografia de estresse com dobutamina (EED) &#233; uma t&#233;cnica confi&#225;vel, mais barata e geralmente mais acess&#237;vel do que a ventriculografia radionucl&#233;ica, o objetivo do presente estudo foi avaliar as mudan&#231;as na fun&#231;&#227;o ventricular esquerda durante a dobutamina em pacientes com regurgita&#231;&#227;o a&#243;rtica e analisar se essas mudan&#231;as se correlacionam com eventos no seguimento dos pacientes.</p>   <p><bold>M&#233;todos</bold></p> <p>Estudaram-se 24 pacientes portadores de regurgita&#231;&#227;o a&#243;rtica de grau moderado em sua maioria. Crit&#233;rios de exclus&#227;o foram: estenose a&#243;rtica associada, pacientes com estenose ou regurgita&#231;&#227;o mitral de grau &gt; leve e cirurgia a&#243;rtica pr&#233;via. Hist&#243;ria cl&#237;nica e eletrocardiograma (ECG) foram obtidos em todos pacientes. O comit&#234; de &#233;tica aprovou o protocolo, e consentimento escrito foi obtido de todos os pacientes.</p> <p>Regurgita&#231;&#227;o a&#243;rtica foi diagnosticada e graduada ao Doppler e Doppler em cores, conforme descri&#231;&#227;o pr&#233;via<sup>12</sup>. As dimens&#245;es card&#237;acas foram medidas pelo modo-M guiado pelo bidimensional, de acordo com crit&#233;rios estabelecidos<sup>13</sup>. A fra&#231;&#227;o de eje&#231;&#227;o (FE) foi calculada tanto pelo m&#233;todo de Teichholz quanto pelo m&#233;todo de &#225;rea-comprimento. Realizaram-se os exames em aparelhos HP 2000 ou 5500 (Hewlett Packard, Andover MA, USA), com transdutores de 3,5 e 2,5 MHz.</p> <p>O protocolo de baixa dose de dobutamina foi realizado em todos os pacientes, inicialmente com a dose de 5 &#181;g/kg/min e depois com incrementos de 5 &#181;g/kg/min a cada tr&#234;s minutos, at&#233; a dose m&#225;xima de 20 &#181;g/kg/min, j&#225; que o objetivo era avaliar a reserva contr&#225;til e isquemia n&#227;o era esperada neste grupo de pacientes. Tanto o ECG como a press&#227;o arterial foram monitorados durante o exame. As dimens&#245;es sist&#243;lica e diast&#243;lica do ventr&#237;culo esquerdo (VE), a FE e os gradientes m&#225;ximo e m&#233;dio a&#243;rticos foram obtidos em todos os est&#225;gios. Um &#237;ndice expressando o percentual de aumento da FE com a dose baixa de dobutamina foi calculado da seguinte forma:</p> <p><graphic xlink:href="1678-4170-abc-93-01-0053-00010-e01.jpg"/></p> <p>O mesmo &#237;ndice foi obtido tamb&#233;m com a utiliza&#231;&#227;o de FE nas doses de 10 &#181;g/kg/min e 15 &#181;g/kg/min. Pacientes foram acompanhados e a hist&#243;ria cl&#237;nica e Doppler ecocardiograma em repouso repetidos no acompanhamento.</p>   <p><bold>An&#225;lise estat&#237;stica</bold></p> <p>Os dados foram expressos como m&#233;dia &#177; desvio padr&#227;o para vari&#225;veis cont&#237;nuas e frequ&#234;ncias para vari&#225;veis categ&#243;ricas. A compara&#231;&#227;o entre grupos de pacientes vivos sem cirurgia e pacientes com eventos para vari&#225;veis cont&#237;nuas e normalmente distribu&#237;das foi feita com o teste <italic>t</italic> de <italic>Student</italic> e a an&#225;lise de vari&#226;ncia, como apropriado (eventos foram considerados troca valvar ou morte card&#237;aca). Analisaram-se dados n&#227;o-param&#233;tricos cont&#237;nuos por meio dos testes de Wilcoxon ou Kruskall-Wallis, conforme apropriado. As diferen&#231;as entre vari&#225;veis categ&#243;ricas foram analisadas pelo teste qui-quadrado. Em todos os casos, a signific&#226;ncia estat&#237;stica foi definida como p &lt; 0,05.</p>   <p><bold>Resultados</bold></p> <p>Os dados cl&#237;nicos de todos os pacientes &#224; entrada do estudo est&#227;o descritos na <xref ref-type="table" rid="t1">tabela 1</xref>.</p> <table-wrap id="t1"><graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt01.jpg"/></table-wrap>   <p>A doen&#231;a reum&#225;tica foi a causa mais prevalente (14 pacientes, 58%); em dois (8%) a causa foi degenerativa, um (4%) apresentava ectasia &#226;nulo-a&#243;rtica, em um a regurgita&#231;&#227;o a&#243;rtica era secund&#225;ria a uma valva a&#243;rtica bic&#250;spide e em outro se desenvolveu ap&#243;s uma cirurgia para corre&#231;&#227;o de comunica&#231;&#227;o interventricular. Em cinco pacientes, a etiologia precisa n&#227;o p&#244;de ser estabelecida.</p> <p>Cinco pacientes (21%) abaixo de 40 anos usavam penicilina para profilaxia de doen&#231;a reum&#225;tica. Oito pacientes (33%) n&#227;o usavam nenhum medicamento; seis (25%) usavam inibidores da enzima conversora, quatro (17%) antagonistas do c&#225;lcio, quatro (17%) betabloqueadores, oito (33%) digoxina e sete (29%) diur&#233;ticos.</p> <p>&#149; <bold><italic>Eletrocardiograma -</italic></bold> dois pacientes (8%) tinham um ECG normal. Do restante, apenas quatro n&#227;o apresentavam sobrecarga de VE: dois tinham anormalidades do segmento ST-T, um extra-s&#237;stoles supraventriculares e um bloqueio isolado do ramo direito. Sobrecarga de VE estava presente em 18 (75%) pacientes. Tr&#234;s destes pacientes tamb&#233;m apresentavam extra-s&#237;stoles supraventriculares, tr&#234;s com bloqueio de ramo direito de graus vari&#225;veis, tr&#234;s tinham algum grau de bloqueio de ramo esquerdo, um tinha bloqueio AV de primeiro grau, um apresentava sobrecarga atrial esquerda e direita, e um estava em fibrila&#231;&#227;o atrial.</p> <p><bold>&#149; <italic>Doppler ecocardiograma -</italic></bold> os valores m&#233;dios dos par&#226;metros ao Doppler dos 24 pacientes em condi&#231;&#245;es basais encontram-se na <xref ref-type="table" rid="t2">tabela 2</xref>.</p> <table-wrap id="t2"><graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt02.jpg"/></table-wrap>   <p><bold>&#149; <italic>Eco de estresse com dobutamina -</italic></bold> todos os pacientes foram submetidos ao protocolo de dose baixa com dobutamina, sem complica&#231;&#245;es. N&#227;o houve efeitos colaterais, e a dose de 20 &#181;g/kg/min foi atingida em todos. Os dados de frequ&#234;ncia card&#237;aca, FE e gradiente m&#233;dio est&#227;o descritos na <xref ref-type="table" rid="t3">tabela 3</xref>, comparativamente entre o exame basal e na dose de 20 &#181;g/kg/min.</p> <table-wrap id="t3"><graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt03.jpg"/></table-wrap>   <p><bold>&#149; <italic>Seguimento dos pacientes -</italic></bold> os pacientes foram acompanhados por 36,6 &#177; 20,1 meses ap&#243;s o estresse com dobutamina. No seguimento, pesquisaram-se os eventos troca valvar a&#243;rtica e morte card&#237;aca, e um novo Doppler ecocardiograma em condi&#231;&#245;es basais foi obtido. Tr&#234;s pacientes n&#227;o retornaram para controle. Dois pacientes faleceram: um, com regurgita&#231;&#227;o moderada e aorta dilatada, morreu de acidente de carro antes que a cirurgia fosse realizada; o outro paciente, que estava em classe III para dispn&#233;ia e tinha angina e s&#237;ncope, morreu por causa de problema valvar. Dados basais, aos 20 &#181;g/kg/min de dobutamina e no seguimento dos 20 pacientes em que o Doppler ecocardiograma de controle foi obtido, est&#227;o descritos na <xref ref-type="table" rid="t4">tabela 4</xref>.</p> <table-wrap id="t4"><graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt04.jpg"/></table-wrap>   <p>A FE com a dobutamina se correlacionou com a FE basal (<xref ref-type="fig" rid="f1">fig. 1</xref>), mas n&#227;o com a FE no seguimento (p = 0,13).</p> <fig id="f1"><graphic xlink:href="1678-4170-abc-93-01-0053-00010-gf01.jpg"/></fig>   <p>Cinco pacientes foram submetidos &#224; cirurgia (dois estavam em classe funcional I e tr&#234;s em classe funcional III no momento em que o ecocardiograma de estresse foi realizado, com indica&#231;&#227;o da cirurgia feita pelo m&#233;dico assistente). O tempo m&#233;dio para a cirurgia ap&#243;s o estresse com dobutamina foi de 11,5 &#177; 5,9 meses. A idade n&#227;o foi estatisticamente diferente entre pacientes operados ou n&#227;o (46,6 &#177; 15,5 x 33,8 &#177; 16,5 anos, p = 0,149) As FE basais dos pacientes que foram operados estavam entre as mais baixas do grupo. Tr&#234;s pacientes melhoraram a classe funcional ap&#243;s a cirurgia, e dois que estavam em classe I permaneceram assintom&#225;ticos no seguimento. Embora tanto os di&#226;metros diast&#243;licos (67,2 &#177; 1,9 &#8594; 50,8 &#177; 1,1; p = 0,043) quanto os sist&#243;licos (45,6 &#177; 1,5 &#8594; 35,2 &#177; 2,7; p = 0,042) tenham diminu&#237;do com a cirurgia, as FE no seguimento dos pacientes operados n&#227;o foram estatisticamente diferentes de suas FE ao in&#237;cio do estudo (59,3 &#177; 3,3% x 59,4 &#177; 9,5%, p = 0,786).</p> <p>O di&#226;metro diast&#243;lico inicial e ao seguimento nos pacientes que sobreviveram sem cirurgia (63,6 &#177; 9,5 e 63,4 &#177; 10,8, respectivamente) n&#227;o diferiu (p = 0,636). O mesmo ocorreu com os di&#226;metros sist&#243;licos (40,3 &#177; 8,1 e 41,1 &#177; 8,8, respectivamente; p = 0,329) e com a FE (67,0 &#177; 7,3% e 63,9 &#177; 8,1%, respectivamente; p = 0,151).</p> <p>Nos 20 pacientes em que se obtiveram dados ecocardiogr&#225;ficos ao seguimento, a FE inicial era mais baixa naqueles que tiveram eventos do que nos que sobreviveram sem cirurgia (59,3 &#177; 3,3 x 66,0 &#177; 7,9; p = 0,016), como demonstra a <xref ref-type="fig" rid="f2">figura 2</xref>. Por&#233;m, o percentual de aumento da FE com a dobutamina n&#227;o foi diferente entre pacientes com eventos e aqueles que sobreviveram sem cirurgia, seja com a dose de 10 &#181;g/kg/min (p = 0,387), de 15 &#181;g/kg/min (p = 0,703) ou de 20 &#181;g/kg/min (p = 0,467).</p> <fig id="f2"><graphic xlink:href="1678-4170-abc-93-01-0053-00010-gf02.jpg"/></fig>   <p><bold>Discuss&#227;o</bold></p> <p>O presente estudo mostrou correla&#231;&#227;o da FE basal com a evolu&#231;&#227;o dos pacientes com regurgita&#231;&#227;o a&#243;rtica. Contudo, a resposta da FE &#224; ecocardiografia de estresse com dobutamina nesse grupo de pacientes n&#227;o foi eficaz em prever eventos.</p> <p>Por causa da preval&#234;ncia ainda alta de doen&#231;a reum&#225;tica em pa&#237;ses em desenvolvimento, o grupo de pacientes com regurgita&#231;&#227;o a&#243;rtica &#233; relativamente jovem, comparado aos pacientes com essa patologia em paises desenvolvidos. Portanto, os resultados deste estudo podem n&#227;o se aplicar a um grupo mais idoso, com regurgita&#231;&#227;o a&#243;rtica degenerativa.</p> <p>Tem sido demonstrado na regurgita&#231;&#227;o a&#243;rtica que mesmo pacientes com FE reduzida podem permanecer assintom&#225;ticos, refletindo o desenvolvimento insidioso da disfun&#231;&#227;o ventricular esquerda e a necessidade de frequentes avalia&#231;&#245;es ventriculares para detectar deteriora&#231;&#227;o adicional antes que uma redu&#231;&#227;o importante ocorra, pois esta pode ter consequ&#234;ncias graves, mesmo ap&#243;s uma troca valvar com sucesso<sup>14</sup>. Estudos da hist&#243;ria natural da regurgita&#231;&#227;o a&#243;rtica t&#234;m focalizado principalmente pacientes assintom&#225;ticos com fun&#231;&#227;o sist&#243;lica normal, mas estudos mais recentes mostram que os resultados sem cirurgia em pacientes mesmo com disfun&#231;&#227;o leve (FE &lt; 55% ou VEs <underline>&gt;</underline> 25 mm/m<sup>2</sup>) s&#227;o ruins. Esses pacientes, mesmo se assintom&#225;ticos ao diagn&#243;stico, apresentam uma mortalidade excessiva em longo prazo se a cirurgia n&#227;o for realizada<sup>15</sup>. A p&#243;s-carga excessiva na regurgita&#231;&#227;o a&#243;rtica, causada pela combina&#231;&#227;o de sobrecarga volum&#233;trica e press&#243;rica, explica em parte a melhora na fun&#231;&#227;o ventricular ap&#243;s a redu&#231;&#227;o da p&#243;s-carga que ocorre com a troca valvar. Assim, a melhora tanto em curto quanto em longo prazos na fun&#231;&#227;o ventricular ap&#243;s a cirurgia se relaciona significativamente &#224; diminui&#231;&#227;o precoce da dilata&#231;&#227;o ventricular ocasionada pela corre&#231;&#227;o da sobrecarga volum&#233;trica<sup>3</sup>.</p> <p>O aumento da FE ap&#243;s a troca valvar na regurgita&#231;&#227;o a&#243;rtica est&#225; em contraste com a situa&#231;&#227;o vista na regurgita&#231;&#227;o mitral, na qual a FE frequentemente diminui ap&#243;s a cirurgia, mesmo se o reparo da valva &#233; realizado com grande sucesso<sup>16,17</sup>. No presente estudo, n&#227;o ocorreu aumento na FE dos pacientes que foram operados, o que pode sugerir que, embora estivessem em classe funcional I (dois pacientes) e II (tr&#234;s pacientes), e suas FE estivessem normais ou discretamente diminu&#237;das ao estudo inicial, eles provavelmente j&#225; tinham uma diminui&#231;&#227;o da reserva contr&#225;til.</p> <p>Em um estudo de 35 pacientes assintom&#225;ticos com graus 3 e 4 de regurgita&#231;&#227;o a&#243;rtica que foram submetidos &#224; ecocardiografia de esfor&#231;o, 21 tiveram aumento da FE de 7 unidades percentuais comparado &#224; FE basal, indicando reserva contr&#225;til. Os outros 14 n&#227;o apresentavam reserva contr&#225;til. O seguimento m&#233;dio foi de 15 meses; 13 dos 21 com reserva contr&#225;til mantiveram fun&#231;&#227;o sist&#243;lica normal, enquanto 13 dos 14 sem reserva contr&#225;til apresentaram uma diminui&#231;&#227;o da FE de 60% para 54%. Neste estudo, a FE basal e a reserva contr&#225;til com o exerc&#237;cio foram os &#250;nicos preditores independentes de uma diminui&#231;&#227;o da fun&#231;&#227;o sist&#243;lica ao seguimento<sup>18</sup>, sugerindo que o exerc&#237;cio seja uma forma melhor de investigar esses pacientes do que o ecocardiograma de estresse com dobutamina. Contudo, este &#233; um dado controverso, pois h&#225; tamb&#233;m evid&#234;ncias de que mesmo pacientes que apresentam diminui&#231;&#227;o da FE ao exerc&#237;cio podem evoluir bem no p&#243;s-operat&#243;rio<sup>19,20</sup>, sugerindo que a queda da FE ao exerc&#237;cio seja multifatorial e deva ser analisada com ressalvas, pois pode n&#227;o se dever necessariamente &#224; disfun&#231;&#227;o ventricular. Existem poucos estudos na literatura usando ecocardiograma de estresse com dobutamina na regurgita&#231;&#227;o a&#243;rtica, geralmente envolvendo um n&#250;mero pequeno de pacientes. Em um deles, com 11 pacientes com regurgita&#231;&#227;o a&#243;rtica e fun&#231;&#227;o sist&#243;lica diminu&#237;da, a dobutamina provocou um aumento da FE basal de 37 &#177; 9 para 43 &#177; 12%, enquanto o estresse sist&#243;lico parietal e press&#227;o sist&#243;lica pulmonar n&#227;o se alteraram. Tr&#234;s pacientes foram submetidos &#224; cirurgia e se tornaram assintom&#225;ticos. Um paciente que n&#227;o aumentou a FE com a dobutamina morreu. Os autores concluem que, em pacientes com regurgita&#231;&#227;o a&#243;rtica e FE reduzida, um aumento da FE e uma redu&#231;&#227;o dos di&#226;metros e volumes ventriculares com a dobutamina s&#227;o vari&#225;veis que indicam reserva contr&#225;til<sup>11</sup>. Contudo, os n&#250;meros foram muito pequenos para permitir qualquer an&#225;lise estat&#237;stica.</p> <p>De Rito e cols.<sup>10</sup>, em outro estudo comparando a ecocardiografia de estresse com dobutamina e a ventriculografia de esfor&#231;o em 26 pacientes com regurgita&#231;&#227;o a&#243;rtica moderada ou grave, constataram concord&#226;ncia entre essas duas modalidades na avalia&#231;&#227;o de pacientes assintom&#225;ticos ou minimamente sintom&#225;ticos.</p> <p>Tam e cols.<sup>9</sup> estudaram 16 pacientes que se submeteram &#224; cirurgia eletiva para regurgita&#231;&#227;o a&#243;rtica e que tinham um ecocardiograma obtido em condi&#231;&#245;es basais e aos 7,5 &#181;g/kg/min de dobutamina. Esses autores compararam os pacientes que tiveram recupera&#231;&#227;o total (normaliza&#231;&#227;o do tamanho e fun&#231;&#227;o ventricular na aus&#234;ncia de sintomas aos seis meses de seguimento) - grupo I - com aqueles que n&#227;o se recuperaram completamente - grupo II. A idade, a classe funcional e os di&#226;metros diast&#243;licos finais foram semelhantes entre os grupos. Contudo, os pacientes do grupo I tinham um &#237;ndice ventricular sist&#243;lico final menor e uma FE maior pr&#233;-operat&#243;rios do que os do grupo II. A dobutamina foi &#250;til em aumentar a diferen&#231;a no tamanho e na fun&#231;&#227;o ventricular dos pacientes dos grupos I e II. Os autores conclu&#237;ram ent&#227;o que a FE durante a infus&#227;o de dobutamina &#233; altamente preditiva da FE p&#243;s-operat&#243;ria e que essa modalidade de ecocardiografia de estresse pode ter um papel na previs&#227;o da resposta cl&#237;nica de pacientes com regurgita&#231;&#227;o a&#243;rtica que v&#227;o ser submetidos &#224; troca valvar a&#243;rtica. Diferentemente desse estudo, os incrementos percentuais da FE aos 10 &#181;g/kg/min, 15 &#181;g/kg/min ou 20 &#181;g/kg/min no nosso estudo n&#227;o foram capazes de predizer cirurgia ou morte no seguimento dos pacientes. Todos os pacientes do estudo de Tam e cols.<sup>9</sup> eram candidatos &#224; cirurgia de troca valvar a&#243;rtica, situa&#231;&#227;o diferente da observada em nossos pacientes, que, na maioria, n&#227;o tinham indica&#231;&#227;o cir&#250;rgica. A ecocardiografia de estresse com dobutamina pode ter tido uma <italic>performance</italic> melhor na discrimina&#231;&#227;o de pacientes com reserva contr&#225;til entre aqueles que j&#225; necessitavam de cirurgia do que entre os pacientes assintom&#225;ticos ou minimamente sintom&#225;ticos. Nestes, o conhecimento da evolu&#231;&#227;o natural da doen&#231;a, a anamnese bem conduzida e os dados de exames como ECG, radiografia de t&#243;rax e ecocardiograma transtor&#225;cico com mapeamento de fluxo em cores parecem ser suficientes, desde que n&#227;o haja dissocia&#231;&#227;o entre exames cl&#237;nicos e complementares.</p> <p><bold>Limita&#231;&#245;es do estudo</bold></p> <p>Este &#233; um grupo pequeno de pacientes, especialmente para analisar eventos no seguimento. Estudos envolvendo um n&#250;mero maior de pacientes s&#227;o necess&#225;rios para confirmar os achados do presente estudo. Al&#233;m disso, nosso grupo de pacientes era bastante heterog&#234;neo no que se refere &#224; idade, etiologia da doen&#231;a reum&#225;tica e dura&#231;&#227;o do seguimento, o que pode ter influenciado os resultados.</p> <p>Tr&#234;s pacientes foram perdidos para o seguimento, e um faleceu em um acidente de carro. Os resultados poderiam ser diferentes se tivessem sido obtidos dados do seguimento desses quatro pacientes.</p>   <p><bold>Conclus&#227;o</bold></p> <p>Nossos achados mostram que, em pacientes jovens com regurgita&#231;&#227;o a&#243;rtica, a FE basal se correlacionou com cirurgia ou morte no seguimento. Contudo, o incremento da FE com infus&#227;o de baixa dose de dobutamina n&#227;o foi capaz de predizer eventos nesses pacientes. Ent&#227;o, com base nesses resultados, a ecocardiografia de estresse com dobutamina n&#227;o parece ser uma ferramenta &#250;til na estratifica&#231;&#227;o de risco de pacientes jovens com regurgita&#231;&#227;o a&#243;rtica. Contudo, novos estudos com n&#250;mero maior de pacientes e de eventos podem apresentar resultados diferentes.</p> <p><bold>Potencial Conflito de Interesses</bold></p> <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p> <p><bold>Fontes de Financiamento</bold></p> <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p> <p><bold>Vincula&#231;&#227;o Acad&#234;mica</bold></p> <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>                      <p>19 Gee DS, Juni JE, Santinga JT, Buda AJ. Prognostic significance of exercise induced left ventricular dysfunction in chronic aortic regurgitation. Am J Cardiol. 1985; 56: 605-9.</p> <p>20 Tarasoutchi F, Grinberg M, Spina GS, Sampaio RO, Cardoso LF, Rossi EG, et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol. 2003; 41: 1316-24.</p>     <p><fn id="back" fn-type="corresp"><label><bold> Correspond&#234;ncia:</bold></label><p>Marcia M. Barbosa  </p><p>Rua Conde do Rio Pardo, 288 </p><p> 34000-000 - Nova Lima, MG - Brasil </p><p>E-mail: </p><p><email xlink:href="marciambarbosa@terra.com.br">marciambarbosa@terra.com.br</email></p></fn></p><p>Artigo recebido em 30/01/08; revisado recebido em 07/04/08; aceito em 10/04/08.</p></body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Bonow RO, Lakatos    E, Maron BJ, Epstein SE. Serial long-term-assessment of the natural history    of asymptomatic patients with chronic aortic regurgitation and normal left ventricular    systolic function. Circulation. 1991; 84: 1625-35.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serial long-term-assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function</article-title>
          <source>Circulation</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>1625</fpage>
          <lpage>35</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bonow</surname>
              <given-names>RO</given-names>
            </name>
            <name>
              <surname>Lakatos</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maron</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Tornos MP, Olona    M, Permanyer-Miralda G, Herrejon MP, Camprecios M, Evangelista A, et al. Clinical    outcome of severe asymptomatic chronic aortic regurgitation: a long term prospective    follow-up study. Am Heart J. 1995; 130: 333-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long term prospective follow-up study</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>333</fpage>
          <lpage>9</lpage>
          <volume>130</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tornos</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Olona</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Permanyer-Miralda</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Herrejon</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Camprecios</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Evangelista</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Bonow RO, Carabello    B, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 Guidelines    for the Management of Patients with Valvular Heart Diseases. J Am Coll Cardiol.    2006; 48: e1-148.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Diseases</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>e1</fpage>
          <lpage>148</lpage>
          <volume>48</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bonow</surname>
              <given-names>RO</given-names>
            </name>
            <name>
              <surname>Carabello</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chatterjee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>de Leon</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Jr.Faxon</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Freed</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. DeFilippi CR,    Willet DW, Brickner ME, Appleton CP, Yancy CW, Eichorn EJ, et al. Usefulness    of dobutamine echocardiography in distinguishing severe from nonsevere valvular    aortic stenosis in patients with depressed left ventricular function and low    transvalvular gradients. Am J Cardiol. 1995; 75: 191-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>191</fpage>
          <lpage>4</lpage>
          <volume>75</volume>
          <person-group person-group-type="author">
            <name>
              <surname>DeFilippi</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Willet</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Brickner</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Appleton</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Yancy</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Eichorn</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Monin JL, Monchi    M, Gest V, Durval-Molin AM, Dubois-Rande JL, Gueret P. Aortic stenosis with    severe left ventricular dysfunction and low transvalvular pressure gradients:    risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol.    2001; 37: 2101-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2101</fpage>
          <lpage>7</lpage>
          <volume>37</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Monin</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Monchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gest</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Durval-Molin</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Dubois-Rande</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Gueret</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Nishimura RA,    Grantham A, Connolly HM, Schaff HV, Higano ST, Holmes DR Jr. Low-output, low-gradient    aortic stenosis in patients with depressed left ventricular systolic function:    the clinical utility of dobutamine challenge in the catheterization laboratory.    Circulation. 2002; 106: 809-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of dobutamine challenge in the catheterization laboratory</article-title>
          <source>Circulation</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>809</fpage>
          <lpage>13</lpage>
          <volume>106</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nishimura</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Grantham</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Schaff</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Higano</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Holmes Jr</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Hecker SL, Zabalgoitia    M, Ashline P, Oneschuk L, O'Rourke R, Herrera C. Comparison of exercise and    dobutamine stress echocardiography in assessing mitral stenosis. Am J Cardiol.    1997; 80: 1374-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of exercise and dobutamine stress echocardiography in assessing mitral stenosis</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1374</fpage>
          <lpage>7</lpage>
          <volume>80</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hecker</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Zabalgoitia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ashline</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Oneschuk</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Herrera</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Reis G, Motta    MS, Barbosa MM, Esteves WA, Souza SF, Bocchi EA. Dobutamine stress echocardiography    for noninvasive assessment and risk stratification of patients with rheumatic    mitral stenosis. J Am Coll Cardiol. 2003; 43 (3): 393-401.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>393</fpage>
          <lpage>401</lpage>
          <issue>3</issue>
          <volume>43</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Reis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Motta</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Esteves</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Bocchi</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Tam JW, Antecol    D, Kim H, Yvorchuk, Chan K. Low dose dobutamine echocardiography in the assessment    of contractile reserve to predict the outcome of valve replacement for chronic    aortic regurgitation. Can J Cardiol. 1999; 15: 73-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Low dose dobutamine echocardiography in the assessment of contractile reserve to predict the outcome of valve replacement for chronic aortic regurgitation</article-title>
          <source>Can J Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>73</fpage>
          <lpage>9</lpage>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tam</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Antecol</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yvorchuk</surname>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. De Rito V,    Natali R, Vigna C, Perna GP, Stanislao M, Lombardo A, et al. Analysis of agreement    between dobutamine stress echocardiography and exercise nuclear angiography    in severe aortic regurgitation. Am J Cardiol. 2000; 86: 104-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Analysis of agreement between dobutamine stress echocardiography and exercise nuclear angiography in severe aortic regurgitation</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>104</fpage>
          <lpage>7</lpage>
          <volume>86</volume>
          <person-group person-group-type="author">
            <name>
              <surname>De Rito</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Natali</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Vigna</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Perna</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Stanislao</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lombardo</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Espinola-Zavaleta    N, G&#243;mez-N&#250;&#241;ez N, Ch&#225;vez PY, Sahagum-Sanches G,    Keirns C, Casanova JM, et al. Evaluation of the response to pharmacological    stress in chronic aortic regurgitation. Echocardiography. 2001; 6: 491-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of the response to pharmacological stress in chronic aortic regurgitation</article-title>
          <source>Echocardiography</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>491</fpage>
          <lpage>6</lpage>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Espinola-Zavaleta</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>G&#243;mez-N&#250;&#241;ez</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ch&#225;vez</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Sahagum-Sanches</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Keirns</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Casanova</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Perry GJ, Helmcke    F, Nanda NC, Bayard C, Soto B. Evaluation of aortic insufficiency by Doppler    color flow mapping. J Am Coll Cardiol. 1987; 9: 952-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of aortic insufficiency by Doppler color flow mapping</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>952</fpage>
          <lpage>9</lpage>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Perry</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Helmcke</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Nanda</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Bayard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Soto</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Sahn DJ, De    Maria A, Kisslo J, Weyman A. Recommendations regarding quantification in M-mode    echocardiography: results of a survey of echocardiographic measurements. Circulation.    1978; 58: 1072-83.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements</article-title>
          <source>Circulation</source>
          <date>
            <year>1978</year>
          </date>
          <fpage>1072</fpage>
          <lpage>83</lpage>
          <volume>58</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sahn</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>De Maria</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kisslo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Weyman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Chaliki HP,    Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ, et al. Outcomes after    aortic valve replacement in patients with severe aortic regurgitation and markedly    reduced left ventricular function. Circulation. 2002; 106: 2687-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function</article-title>
          <source>Circulation</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>2687</fpage>
          <lpage>93</lpage>
          <volume>106</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chaliki</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Mohty</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Avierinos</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Schaff</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Tajik</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Dujardin K,    Enriquez-Sarano M, Schaff H, Bailey K, Seward J, Tajik A. Mortality and morbidity    of severe aortic regurgitation in clinical practice: a long-term follow up study.    Circulation. 1999; 99: 1851-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mortality and morbidity of severe aortic regurgitation in clinical practice: a long-term follow up study</article-title>
          <source>Circulation</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1851</fpage>
          <lpage>7</lpage>
          <volume>99</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dujardin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Enriquez-Sarano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schaff</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Seward</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tajik</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Wisenbaugh    T, Spann J, Carabello B. Differences in myocardial performance and load between    patients with similar amount of chronic aortic versus chronic mitral regurgitation.    J am Coll Cardiol. 1984; 3: 916-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Differences in myocardial performance and load between patients with similar amount of chronic aortic versus chronic mitral regurgitation</article-title>
          <source>J am Coll Cardiol</source>
          <date>
            <year>1984</year>
          </date>
          <fpage>916</fpage>
          <lpage>23</lpage>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wisenbaugh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Spann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Carabello</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Enriquez-Sarano    M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves    the outcome of surgery for mitral regurgitation: a multivariate analysis. Circulation.    1995; 91: 1022-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Valve repair improves the outcome of surgery for mitral regurgitation: a multivariate analysis</article-title>
          <source>Circulation</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1022</fpage>
          <lpage>8</lpage>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Enriquez-Sarano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schaff</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Orszulak</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Tajik</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Frye</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Lindsay J,    Silverman A, Van Voorhees LB, Nolan NG. Prognostic implications of left ventricular    function during exercise in asymptomatic patients with aortic regurgitation.    Angiology. 1987; 38: 386-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic implications of left ventricular function during exercise in asymptomatic patients with aortic regurgitation</article-title>
          <source>Angiology</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>386</fpage>
          <lpage>92</lpage>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lindsay</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Silverman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Van Voorhees</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Nolan</surname>
              <given-names>NG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Dobutamine-stress echocardiography in asymptomatic patients with aortic regurgitation</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Decreased contractile reserve may already be present in asymptomatic patients with aortic regurgitation and normal ejection fraction (EF), thus indicating the need for frequent and accurate assessments of the left ventricular function for the early detection of systolic dysfunction. OBJECTIVE: To analyze if increments in EF with low dose dobutamine could predict surgery and/or death in patients with aortic regurgitation. METHDOS: Dobutamine-stress echocardiography was performed in 24 patients with aortic regurgitation in order to analyze whether EF increments at low dobutamine doses could predict the need for surgery and/or death in this group of patients. RESULTS: Mean age was 37.8&#177;16.8 years and 16 patients (66%) were male. EF increased from a mean baseline value of 62.3&#177;7.9% to 71.5&#177;10.5% at a dobutamine dose of 20 &#181;g/kg/min (p&lt;0.001). The patients were followed-up for 36.6&#177;20.1 months; two patients died (one of cardiovascular death) and five underwent cardiac surgery. Baseline EF was correlated with surgery and death in the follow-up of patients. CONCLUSION: Baseline EF was correlated with surgery or death in the follow-up of young patients with aortic regurgitation. However, the percentage increase in EF at low dobutamine doses did not allow us to predict events in these patients.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Echocardiography, stress</kwd>
        <kwd>dobutamine</kwd>
        <kwd>patients</kwd>
        <kwd>aortic valve insufficiency</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Dobutamine-stress echocardiography in asymptomatic patients with aortic regurgitation</bold>
          </label>
          <p>
            <bold>Marcia M. Barbosa<sup>II</sup>; Claudia M. V. Freire<sup>I, II</sup>; L&#250;cia M. A. Fenelon<sup>II</sup>; William A. M. Esteves<sup>I</sup>; Gilmar Reis<sup>II</sup>; Maria do Carmo P. Nunes<sup>I, II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade Federal de Minas Gerais, Belo Horizonte, MG - Brazil</p>
      <p><sup>II</sup>Ecocenter, Hospital Socor, Belo Horizonte, MG - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>SUMMARY</bold>
      </p>
      <p><bold>BACKGROUND: </bold> Decreased contractile reserve may already be present in asymptomatic patients with aortic regurgitation and normal ejection fraction (EF), thus indicating the need for frequent and accurate assessments of the left ventricular function for the early detection of systolic dysfunction.</p>
      <p><bold>OBJECTIVE:</bold> To analyze if increments in EF with low dose dobutamine could predict surgery and/or death in patients with aortic regurgitation.</p>
      <p><bold>METHODS:</bold> Dobutamine-stress echocardiography was performed in 24 patients with aortic regurgitation in order to analyze whether EF increments at low dobutamine doses could predict the need for surgery and/or death in this group of patients.</p>
      <p><bold>RESULTS:</bold> Mean age was 37.8&#177;16.8 years and 16 patients (66%) were male. EF increased from a mean baseline value of 62.3&#177;7.9% to 71.5&#177;10.5% at a dobutamine dose of 20 &#956;g/kg/min (p&lt;0.001). The patients were followed-up for 36.6&#177;20.1 months; two patients died (one of cardiovascular death) and five underwent cardiac surgery. Baseline EF was correlated with surgery and death in the follow-up of patients.</p>
      <p><bold>CONCLUSION:</bold> Baseline EF was correlated with surgery or death in the follow-up of young patients with aortic regurgitation. However, the percentage increase in EF at low dobutamine doses did not allow us to predict events in these patients.</p>
      <p><bold>Key words:</bold> Echocardiography, stress; dobutamine; patients; aortic valve insufficiency.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>It is difficult to define the surgical time for aortic valve replacement in patients with significant aortic regurgitation in the absence of symptoms. Previous studies suggest that asymptomatic patients have a good prognosis<sup>1,2</sup>. However, the outcome of patients with mild symptoms or of asymptomatic patients that could nevertheless be exposed to a high risk of ventricular dysfunction is not established. It is necessary to assess early valve replacement accurately, since the natural history of aortic regurgitation is usually benign and the surgical mortality rate of valve replacement is low, but not negligible. Additionally, the long-term performance of valve prostheses is uncertain.</p>
      <p>Several studies have demonstrated that even asymptomatic patients with aortic regurgitation and normal left ventricular function can show an abnormal response of ventricular function to exercise. Left ventricular dysfunction during exercise is an important predictor of prognosis in chronic aortic regurgitation; however, this is not easy to define and its mechanism is not fully understood. It seems to be multifactorial, not necessarily indicating LV dysfunction. Radionuclide ventriculography is frequently performed in asymptomatic patients for the detection of early left ventricular dysfunction, although this study modality is a class IIb in the American guidelines<sup>3</sup>. Stress echocardiography has been often used for the diagnosis of coronary artery disease, and occasionally in the course of selected cases of heart valve diseases, such as aortic stenosis<sup>4-6</sup>, mitral stenosis<sup>7,8</sup>, and aortic regurgitation<sup>9-11</sup>.</p>
      <p>Since dobutamine-stress echocardiography (DSE) is a reliable technique that is less expensive and usually more easily available than radionuclide ventriculography, the objective of the present study was to assess the changes in left ventricular function during dobutamine stress in patients with aortic regurgitation and to analyze whether these changes are correlated with events in the follow-up of the patients.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>A total of 24 patients with aortic regurgitation, most of which moderate, were studied. Exclusion criteria were: associated aortic stenosis, patients with &gt; mild mitral stenosis or regurgitation, and previous aortic surgery. Clinical history and electrocardiogram (ECG) were obtained from all patients. The protocol was approved by the ethics committee and a written informed consent was obtained from all patients.</p>
      <p>Aortic regurgitation was diagnosed and graded by Doppler and color Doppler as described elsewhere<sup>12</sup>. Cardiac dimensions were measured by the two-dimensional guided M-mode, according to established criteria<sup>13</sup>. Ejection fraction (EF) was calculated using both the Teichholz and the area-length methods. The studies were performed in HP 2000 or 5500 (Hewlett Packard, Andover MA, USA) instruments, with 3.5 and 2.5 MHz transducers.</p>
      <p>The low-dose dobutamine protocol was performed in all patients, with an initial dose of 5 &#181;g/kg/min followed by incremental doses of 5 &#181;g/kg/min every three minutes, up to the maximum dose of 20 &#181;g/kg/min, since the objective was to assess the contractile reserve, and ischemia was not expected among this group of patients. Both ECG and blood pressure were monitored during the test. Left ventricular (LV) systolic and diastolic diameters, EF, and maximum and mean aortic gradients were obtained in all stages. The index expressing the percentage of EF elevation with the low dobutamine dose was calculated using the formula:</p>
      <p>
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-e01-en.jpg"/></p>
      <p>The same index was obtained using EF at the 10&#181;g/kg/min and 15&#181;g/kg/min doses. The patients were followed-up and clinical history as well as resting Doppler echocardiography were repeated during the follow-up.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Data were expressed as mean &#177; standard deviation for continuous variables and as frequencies for categorical variables. The Student's t test and analysis of variance were used, as appropriate, for comparison between groups of living patients not undergoing surgery and patients with events for continuous variables normally distributed (events were defined as valve replacement or cardiac death). Continuous non-parametric data were analyzed using the Wilcoxon or Kruskall-Wallis test, as appropriate. The differences between categorical variables were analyzed using the chi-square test. In all cases, the statistical significance was set at p&lt;0.05.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Clinical data of all patients at enrollment are shown in <xref ref-type="table" rid="t1-body2">Table 1</xref>.</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt01-en.jpg"/></table-wrap>
      <p>Rheumatic disease was the most prevalent cause (14 patients, 58%); in two patients (8%) the etiology was degenerative disease, one (4%) had annuloaortic ectasia, in one patient the aortic regurgitation was secondary to bicuspid aortic valve, and in another it developed after surgery for correction of ventricular septal defect. In five patients the exact etiology could not be established.</p>
      <p>Five patients (21%) less than 40 years old were taking penicillin for prophylaxis of rheumatic disease. Eight patients (33%) were not taking any type of medication; six (25%) were taking converting-enzyme inhibitors, four (17%) were taking calcium antagonists, four (17%) beta-blockers, eight (33%) digoxin and seven (29%) diuretics.</p>
      <p><italic>&#149; ECG -</italic> Two patients (8%) had normal ECG. Of the remaining, only four did not present LV overload: two had ST-T segment changes, one had supraventricular extrasystoles, and one patient had right ventricular branch block alone. LV overload was present in 18 (75%) patients. Three of these patients also had supraventricular extrasystoles, three with right bundle branch block of varying degrees, three had some degree of left bundle branch block, one had first-degree AV block, one had right and left atrial overload, and one had atrial fibrillation.</p>
      <p>&#149; <italic>Doppler echocardiography -</italic> Mean baseline values of Doppler parameters of the 24 patients are shown in <xref ref-type="table" rid="t2-body2">Table 2</xref>.</p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt02-en.jpg"/></table-wrap>
      <p>&#149; <italic>Dobutamine-stress echocardiography -</italic> All patients underwent the low-dose dobutamine protocol with no complications. No collateral effects were observed and the 20 &#181;g/kg/min dose was reached in all patients. Comparative data on heart rate, EF, and mean gradient between baseline and dobutamine-stress test at the 20-&#181;g/kg/min dose are shown in <xref ref-type="table" rid="t3-body2">Table 3</xref>.</p>
      <table-wrap id="t3-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt03-en.jpg"/></table-wrap>
      <p>&#149; <italic>Follow-up of the patients -</italic> The patients were followed-up for 36.6&#177;20.1 months after the dobutamine-stress test. During follow-up, the events aortic valve replacement and cardiac death were observed, and a new Doppler echocardiogram was obtained at baseline conditions. Three patients did not attend the appointment for control. Two patients died: one with moderate regurgitation and dilated aorta died in a car accident before undergoing surgery; the other, who was in class III for dyspnea and had angina and syncope, died of the heart valve disease. Data at baseline, at 20-&#181;g/kg/min dobutamine stress test, and in the follow-up of the 20 patients from whom the control Doppler echocardiogram was obtained are shown in <xref ref-type="table" rid="t4-body2">Table 4</xref>.</p>
      <table-wrap id="t4-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt04-en.jpg"/></table-wrap>
      <p>EF with dobutamine was correlated with baseline EF (<xref ref-type="fig" rid="f1-body2">Figure 1</xref>), but not with EF in the follow-up (p=0.13).</p>
      <fig id="f1-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gf01-en.jpg"/></fig>
      <p>Five patients underwent surgery (two were in functional class I and three in functional class III at the moment the stress echocardiography was performed, and surgery was indicated by the attending physician). Mean time for surgery after the dobutamine stress test was 11.5&#177;5.9 months. Age was not statistically different between patients undergoing surgery and those not undergoing surgery (46.6&#177;15.5 vs. 33.8&#177;16.5 years, p=0.149). Baseline EF values of patients undergoing surgery were among the lowest in the group. There was improvement of the functional class in three patients after surgery, and two patients who were in class I remained asymptomatic during the follow-up. Although both diastolic (67.2&#177;1.9 &#8594; 50.8&#177;1.1; p=0.043) and systolic (45.6&#177;1.5 &#8594; 35.2&#177;2.7; p=0.042) diameters had decreased with surgery, the EF measured in the follow-up of the patients undergoing surgery were not statistically different from the EF at the beginning of the study (59.3&#177;3.3% <italic>vs</italic> 59.4&#177;9.5%, p=0.786).</p>
      <p>The initial diastolic diameter and at follow-up of the patients who survived without undergoing surgery (63.6&#177;9.5 and 63.4&#177;10.8, respectively) were not statistically different (p=0.636). The same occurred with the systolic diameters (40.3&#177;8.1 and 41.1&#177;8.8, respectively; p=0.329) and with EF (67.0&#177;7.3% and 63.9&#177;8.1%, respectively; p=0.151).</p>
      <p>In the 20 patients from whom echocardiographic data were obtained during follow-up, the initial EF was lower in patients who had events than in those who survived without surgery (59.3&#177;3.3 vs. 66.0&#177;7.9; p=0.016), as shown in <xref ref-type="fig" rid="f2-body2">Figure 2</xref>. However, the percentage increase of EF with dobutamine was not different between patients with events and those who survived without surgery, whether at the 10&#181;g/kg/min (p=0.387), 15&#181;g/kg/min (p=0.703) or 20&#181;g/kg/min (p= 0.467) dose.</p>
      <fig id="f2-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gf02-en.jpg"/></fig>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The present study showed a correlation of baseline EF with the outcome of patients with aortic regurgitation. However, the EF response to dobutamine-stress echocardiography in this group of patients did not show efficiency at predicting events.</p>
      <p>Due to the still high prevalence of rheumatic disease in developing countries, our group of patients with aortic regurgitation is relatively young in comparison with patients with this disease in developed countries. However, the results of this study may not apply to a group of older patients with degenerative aortic regurgitation.</p>
      <p>In aortic regurgitation, it has been demonstrated that even patients with decreased EF may remain asymptomatic, thus reflecting the insidious development of left ventricular dysfunction and the need for frequent ventricular assessments in order to detect additional deterioration before a marked reduction occurs, because this may have severe consequences even after a successful valve replacement<sup>14</sup>. Studies on the natural history of aortic regurgitation have focused mainly on asymptomatic patients with normal systolic function; however, more recent studies demonstrated that the outcomes without surgery in patients even with mild dysfunction (EF &lt; 55% or LVs <underline>&gt;</underline> 25mm/m<sup>2</sup>) are poor. Even when asymptomatic at diagnosis, these patients incur excess long-term mortality if surgery is not performed<sup>15</sup>. The excessive afterload in aortic regurgitation caused by the combination of volumetric and pressure overload partly explains the improved ventricular function after reduction of the afterload that follows valve replacement. Thus, both the short-term and long-term improvement in ventricular function after surgery is significantly related to the early reduction of ventricular dilation resulting from the correction of the volume overload<sup>3</sup>.</p>
      <p>The increased EF following valve replacement in aortic regurgitation contrasts with the situation observed in mitral regurgitation, in which the EF commonly decreases after surgery, even when the valve repair is very successfully performed<sup>16,17</sup>. In the present study, EF did not increase in patients undergoing surgery, which may suggest that, although they were in functional class I (two patients) and II (three patients) and their EF were normal or slightly decreased at the initial study, they probably already had a decreased contractile reserve.</p>
      <p>In a study of 35 asymptomatic patients with grades 3 and 4 aortic regurgitation who underwent exercise echocardiography, 21 had EF increased by 7 units percent in comparison with baseline EF, thus indicating contractile reserve. The other 14 patients did not present contractile reserve. The mean follow-up period was 15 months; the systolic function of 13 out of the 21 patients with contractile reserve remained normal, whereas the EF of 13 out of the 14 patients without contractile reserve decreased from 60% to 54%. In this study, the baseline EF and contractile reserve with exercise were the only independent predictors of decreased systolic function during follow-up<sup>18</sup>, thus suggesting that exercise is a better tool for investigating these patients than dobutamine-stress echocardiography. However, this is a controversial finding, because there is evidence that even patients who present decreased EF at exercise may have a good outcome in the postoperative period<sup>19,20</sup>, thus suggesting that the reduction in EF at exercise is multifactorial and should be analyzed with reservation, because it may not necessarily be due to ventricular dysfunction. Few studies using dobutamine-stress echocardiography in aortic regurgitation are available in the literature, and they usually analyze a small number of patients. In one of them which analyzed 11 patients with aortic regurgitation and decreased systolic function, dobutamine led to an elevation of baseline EF from 37&#177;9 to 43&#177;12%, whereas the systolic wall stress and systolic pulmonary pressure did not change. Three patients underwent surgery and became asymptomatic. One patient whose EF did not increase with dobutamine died. The authors conclude that in patients with aortic regurgitation and decreased EF, dobutamine-induced elevation of EF and reduction of ventricular diameters and volumes are variables that indicate contractile reserve<sup>11</sup>. However, the samples were very small to enable any statistical analysis.</p>
      <p>In another study comparing dobutamine-stress echocardiography and exercise ventriculography in 26 patients with moderate to severe aortic regurgitation, De Rito et al<sup>10</sup> showed concordance between these two modalities in the assessment of asymptomatic or minimally symptomatic patients.</p>
      <p>Tam et al<sup>9</sup> studied 16 patients who underwent elective surgery for aortic regurgitation and had echocardiograms obtained at baseline and at 7.5&#181;g/kg/min dobutamine. They compared patients with full recovery (normalization of ventricular size and function in the absence of symptoms at six months of follow-up) - Group I, to those without full recovery - Group II. Age, functional class and end-diastolic diameters were similar between the groups. However, patients in Group I had a lower preoperative end-systolic ventricular index and higher EF than patients in Group II. Dobutamine was useful in increasing the difference in ventricular size and function of patients of Groups I and II. The authors then concluded that EF during dobutamine infusion is highly predictive of postoperative EF, and that this modality of stress-echocardiography may play a role in the prediction of the clinical response of patients with aortic regurgitation who are undergoing aortic valve replacement. Differently from that study, the percentage increases of EF at 10&#181;g/kg/min, 15&#181;g/kg/min or 20&#181;g/kg/min in our study did not permit prediction of surgery or death in the follow-up of the patients. All patients in Tam et al<sup>9</sup> study were eligible for aortic valve replacement, a situation different from that of our patients, for most of whom surgery was not indicated. Dobutamine-stress echocardiography may have had a better performance to discriminate patients with contractile reserve among those who already required surgery than among those asymptomatic or minimally symptomatic. In the latter, the knowledge of the natural progression of the disease, a well-performed history taking, and results of tests such as ECG, chest radiography, and transthoracic echocardiography with color flow mapping seem to be enough, provided that there is no dissociation between the clinical manifestations and the ancillary tests.</p>
      <p>
        <bold>Study limitations</bold>
      </p>
      <p>This is a small group of patients, especially for the analysis of follow-up events. Further studies including a larger number of patients are required to confirm the findings of the present study. Additionally, our group of patients was quite heterogeneous in terms of age, etiology of rheumatic disease, and follow-up duration, and these may have influenced the results.</p>
      <p>Three patients were lost to follow-up and one patient died in a car accident. The results could be different if data on the follow-up of these four patients had been obtained.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>Our findings showed that in young patients with aortic regurgitation baseline EF was correlated to surgery or death in the follow-up. However, EF elevation induced by dobutamine infusion at low-doses did notpermit the prediction of events in these patients. Thus, based on these results, dobutamine-stress echocardiography does not seem to be a useful tool in risk stratification of young patients with aortic regurgitation. However, further studies with larger number of patients and events may show different results.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This study is not associated with any post-graduation program.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Ecocardiograf&#237;a bajo estr&#233;s con dobutamina en pacientes asintom&#225;ticos con regurgitaci&#243;n a&#243;rtica</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La reserva contr&#225;ctil disminuida puede ya estar presente en pacientes portadores de regurgitaci&#243;n a&#243;rtica, asintom&#225;ticos con fracci&#243;n de eyecci&#243;n (FE) normal, indicando la necesidad de evaluaciones frecuentes y cuidadosas de la funci&#243;n ventricular izquierda para detectar disfunci&#243;n sist&#243;lica incipiente. OBJETIVO: Analizar se incrementos en la FE en dosis bajas de dobutamina pueden predecir cirug&#237;a y/o muerte en pacientes con regurgitaci&#243;n a&#243;rtica. M&#201;TODOS: Eco de estr&#233;s con dobutamina se realiz&#243; en 24 pacientes portadores de regurgitaci&#243;n a&#243;rtica para verificar se incrementos de la FE en dosis bajas de dobutamina ser&#237;an capaces de predecir la necesidad de cirug&#237;a y/o muerte en ese grupo de pacientes. RESULTADOS: La edad promedio fue de 37,8&#177;16,8, y 16 (66%) eran varones. La FE aument&#243; de un valor basal promedio de 62,3&#177;7,9% para 71,5&#177;10,5%, en la dosis de 20 &#181;g/kg/min de dobutamina (p &lt; 0,001). Los pacientes se siguieron por 36,6&#177;20,1 meses: dos pacientes murieron (uno de muerte cardiovascular) y cinco se sometieron a cirug&#237;a cardiaca. La FE basal se correlacion&#243; con cirug&#237;a y muerte en el seguimiento de pacientes. CONCLUSI&#211;N: La fe basal se correlacion&#243; con cirug&#237;a o muerte en el seguimiento de pacientes j&#243;venes con regurgitaci&#243;n a&#243;rtica. Sin embargo, el incremento porcentual en la FE con dosis baja de dobutamina no fue capaz de predecir eventos en esos pacientes.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Ecocardiograf&#237;a bajo estr&#233;s</kwd>
        <kwd>dobutamina</kwd>
        <kwd>pacientes</kwd>
        <kwd>insuficiencia de la v&#225;lvula a&#243;rtica</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Ecocardiograf&#237;a bajo estr&#233;s con dobutamina en pacientes asintom&#225;ticos con regurgitaci&#243;n a&#243;rtica</bold>
          </label>
          <p>
            <bold>Marcia M. Barbosa<sup>II</sup>; Claudia M. V. Freire<sup>I, II</sup>; L&#250;cia M. A. Fenelon<sup>II</sup>; William A. M. Esteves<sup>I</sup>; Gilmar Reis<sup>II</sup>; Maria do Carmo P. Nunes<sup>I, II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade Federal de Minas Gerais</p>
      <p><sup>II</sup>Ecocenter, Hospital Socor, Belo Horizonte, MG - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold> La reserva contr&#225;ctil disminuida puede ya estar presente en pacientes portadores de regurgitaci&#243;n a&#243;rtica, asintom&#225;ticos con fracci&#243;n de eyecci&#243;n (FE) normal, indicando la necesidad de evaluaciones frecuentes y cuidadosas de la funci&#243;n ventricular izquierda para detectar disfunci&#243;n sist&#243;lica incipiente.</p>
      <p><bold>OBJETIVO: </bold> Analizar se incrementos en la FE en dosis bajas de dobutamina pueden predecir cirug&#237;a y/o muerte en pacientes con regurgitaci&#243;n a&#243;rtica.</p>
      <p><bold>M&#201;TODOS: </bold> Eco de estr&#233;s con dobutamina se realiz&#243; en 24 pacientes portadores de regurgitaci&#243;n a&#243;rtica para verificar se incrementos de la FE en dosis bajas de dobutamina ser&#237;an capaces de predecir la necesidad de cirug&#237;a y/o muerte en ese grupo de pacientes.</p>
      <p><bold>RESULTADOS: </bold> La edad promedio fue de 37,8&#177;16,8, y 16 (66%) eran varones. La FE aument&#243; de un valor basal promedio de 62,3&#177;7,9% para 71,5&#177;10,5%, en la dosis de 20 &#181;g/kg/min de dobutamina (p &lt; 0,001). Los pacientes se siguieron por 36,6&#177;20,1 meses: dos pacientes murieron (uno de muerte cardiovascular) y cinco se sometieron a cirug&#237;a cardiaca. La FE basal se correlacion&#243; con cirug&#237;a y muerte en el seguimiento de pacientes.</p>
      <p><bold>CONCLUSI&#211;N: </bold> La fe basal se correlacion&#243; con cirug&#237;a o muerte en el seguimiento de pacientes j&#243;venes con regurgitaci&#243;n a&#243;rtica. Sin embargo, el incremento porcentual en la FE con dosis baja de dobutamina no fue capaz de predecir eventos en esos pacientes.</p>
      <p><bold>Palabras-clave: </bold> Ecocardiograf&#237;a bajo estr&#233;s, dobutamina, pacientes, insuficiencia de la v&#225;lvula a&#243;rtica.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>El momento quir&#250;rgico del cambio valvular a&#243;rtico en pacientes con regurgitaci&#243;n a&#243;rtica importante es dif&#237;cil de definir ante la ausencia de s&#237;ntomas. Estudios previos sugieren que pacientes asintom&#225;ticos tienen un bueno pron&#243;stico<sup>1,2</sup>. Sin embargo, la evoluci&#243;n de los pacientes poco sintom&#225;ticos o del subgrupo asintom&#225;tico, pero que pueden estar expuestos a un riesgo elevado de disfunci&#243;n ventricular, no est&#225; establecida. Es necesario que se eval&#250;e bien el cambio valvular precoz, ya que la historia natural de la regurgitaci&#243;n a&#243;rtica es, en general, benigna y la tasa de mortalidad quir&#250;rgica del cambio valvular es peque&#241;a, pero no despreciable. Adem&#225;s de ello, existe incertidumbre en cuanto a la funci&#243;n a largo plazo de las pr&#243;tesis valvulares.</p>
      <p>Diversos estudios han evidenciado que incluso pacientes asintom&#225;ticos con regurgitaci&#243;n a&#243;rtica y funci&#243;n ventricular izquierda normal pueden presentar una respuesta anormal de la funci&#243;n ventricular al esfuerzo. Disfunci&#243;n ventricular izquierda durante el esfuerzo es un predictor importante del pron&#243;stico de la regurgitaci&#243;n a&#243;rtica cr&#243;nica. No obstante, &#233;sta no es f&#225;cil de definir, ni su mecanismo est&#225; completamente establecido, pareciendo ser multifactorial, no indicando necesariamente disfunci&#243;n de ventr&#237;culo izquierdo (VI). La ventriculograf&#237;a con radion&#250;clidos es frecuentemente realizada en pacientes asintom&#225;ticos para detectar disfunci&#243;n ventricular izquierda precoz, aunque esa modalidad de examen sea clase IIB en las directrices americanas<sup>3</sup>. La ecocardiograf&#237;a de estr&#233;s ha sido intensamente utilizada en el diagn&#243;stico de la enfermedad coronaria y ocasionalmente en la evoluci&#243;n de casos seleccionados de enfermedades valvulares, como estenosis a&#243;rtica<sup>4-6</sup>, estenosis mitral<sup>7,8</sup> y regurgitaci&#243;n a&#243;rtica<sup>9-11</sup>.</p>
      <p>Como la ecocardiograf&#237;a de estr&#233;s con dobutamina (EED) es una t&#233;cnica confiable, m&#225;s barata y generalmente m&#225;s accesible que la ventriculograf&#237;a con radion&#250;clidos, el objetivo del presente estudio fue evaluar los cambios en la funci&#243;n ventricular izquierda durante la dobutamina en pacientes con regurgitaci&#243;n a&#243;rtica y analizar si esos cambios se correlacionan con eventos en el seguimiento de los pacientes.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Se estudiaron a 24 pacientes portadores de regurgitaci&#243;n a&#243;rtica de grado moderado en su mayor&#237;a. Los criterios de exclusi&#243;n fueron: estenosis a&#243;rtica asociada, pacientes con estenosis o regurgitaci&#243;n mitral de grado &gt; leve y cirug&#237;a a&#243;rtica previa. Se obtuvieron la historia cl&#237;nica y el electrocardiograma (ECG) en todos los pacientes. El comit&#233; de &#233;tica aprob&#243; el protocolo, y se obtuvo el consentimiento informado de todos los pacientes.</p>
      <p>Se diagnostic&#243; y gradu&#243; la regurgitaci&#243;n a&#243;rtica con empleo de Doppler y Doppler color, de acuerdo con descripci&#243;n previa<sup>12</sup>. Las dimensiones cardiacas se midieron por el modo-M, guiado por el bidimensional, de acuerdo con criterios establecidos<sup>13</sup>. La fracci&#243;n de eyecci&#243;n (FE) se calcul&#243; tanto con el m&#233;todo de Teichholz como por el m&#233;todo de &#225;rea-longitud. Se llevaron a cabo ex&#225;menes en aparatos HP 2000 &#243; 5500 (Hewlett Packard, Andover MA, USA), con transductores de 3,5 y 2,5 MHz.</p>
      <p>El protocolo de baja dosis de dobutamina se realiz&#243; en todos los pacientes, inicialmente con la dosis de 5 &#181;g/kg/min y, seguidamente, con incrementos de 5 &#181;g/kg/min a cada tres minutos, hasta la dosis m&#225;xima de 20 &#181;g/kg/min, ya que el objetivo era evaluar la reserva contr&#225;ctil e isquemia no era esperada en este grupo de pacientes. Hubo el monitoreo tanto del ECG como de la presi&#243;n arterial durante el examen. Las dimensiones sist&#243;lica y diast&#243;lica del ventr&#237;culo izquierdo (VI), la FE y los gradientes m&#225;ximo y promedio a&#243;rticos se obtuvieron en todos los estadios. Un &#237;ndice expresando el porcentual de aumento de la FE con la dosis baja de dobutamina se calcul&#243; de la siguiente forma:</p>
      <p>
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-e01-es.jpg"/></p>
      <p>El mismo &#237;ndice se obtuvo tambi&#233;n con la utilizaci&#243;n de FE en las dosis de 10 &#181;g/kg/min y 15 &#181;g/kg/min. A los pacientes se les siguieron y se repiti&#243; la historia cl&#237;nica y la ecocardiograf&#237;a Doppler en reposo en el seguimiento.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Los datos se expresaron como promedio &#177; desviaci&#243;n est&#225;ndar para variables continuas y frecuencias para variables categ&#243;ricas. La comparaci&#243;n entre grupos de pacientes vivos sin cirug&#237;a y pacientes con eventos para variables continuas y normalmente distribuidas se hizo con la prueba <italic>t</italic> de <italic>Student</italic> y el an&#225;lisis de varianza, como apropiado (se consideraron los eventos como reemplazo valvular o muerte cardiaca). Se analizaron los datos no-param&#233;tricos continuos por medio de las pruebas de Wilcoxon o Kruskall-Wallis, de acuerdo con el apropiado. Las diferencias entre variables categ&#243;ricas se analizaron mediante la prueba chi-cuadrado. En todos los casos, la significancia estad&#237;stica se defini&#243; como p &lt; 0,05.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Los datos cl&#237;nicos de todos los pacientes a la entrada del estudio est&#225;n descriptos en la <xref ref-type="table" rid="t1-body3">Tabla 1</xref>.</p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt01-es.jpg"/></table-wrap>
      <p>La enfermedad reum&#225;tica fue la causa m&#225;s prevalente (14 pacientes, el 58%); en dos de ellos (8%) la causa fue degenerativa, en uno (4%) presentaba ectasia anulo a&#243;rtica, en uno otro la regurgitaci&#243;n a&#243;rtica era secundaria a una v&#225;lvula a&#243;rtica bic&#250;spide, y en otro se desarroll&#243; tras una cirug&#237;a para correcci&#243;n de comunicaci&#243;n interventricular. En cinco pacientes no se pudo establecer la etiolog&#237;a exacta.</p>
      <p>Cinco pacientes (21%) abajo de los 40 a&#241;os recib&#237;an tratamiento con penicilina para profilaxis de enfermedad reum&#225;tica. Ocho pacientes (33%) no tomaban ning&#250;n tipo de medicaci&#243;n; 6 (25%) estaban en tratamiento con inhibidores de la enzima conversora, 4 (17%) con antagonistas del calcio, 4 (17%) con betabloqueantes, 8 (33%) con digoxina y 7 (29%) con diur&#233;ticos.</p>
      <p><italic>&#149; Electrocardiograma -</italic> dos pacientes (8%) ten&#237;an un ECG normal. De los pacientes restantes, solamente 4 no presentaban sobrecarga de VI: Dos pacientes ten&#237;an anormalidades del segmento ST-T, uno ten&#237;a extras&#237;stoles supraventriculares y otro ten&#237;a un bloqueo aislado de la rama derecha. Sobrecarga de VI estaba presente en 18 (75%) pacientes. Tres de ellos tambi&#233;n presentaban extras&#237;stoles supraventriculares, tres con bloqueo de rama derecha de grados variables, tres ten&#237;an alg&#250;n grado de bloqueo de rama izquierda, uno ten&#237;a bloqueo AV de primer grado, uno presentaba sobrecarga atrial izquierda y derecha, y uno estaba en fibrilaci&#243;n atrial.</p>
      <p><italic>&#149; Doppler ecocardiograf&#237;a -</italic> los valores promedios de los par&#225;metros al Doppler de los 24 pacientes en condiciones basales est&#225;n presentados en la <xref ref-type="table" rid="t2-body3">Tabla 2</xref>.</p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt02-es.jpg"/></table-wrap>
      <p><italic>&#149; Eco de estr&#233;s con dobutamina -</italic> todos los pacientes se sometieron al protocolo de dosis baja con dobutamina, sin complicaciones. No hubo efectos colaterales, y se alcanz&#243; la dosis de 20 &#181;g/kg/min en todos ellos. Los datos de frecuencia cardiaca, FE y gradiente promedio est&#225;n descriptos en la <xref ref-type="table" rid="t3-body3">Tabla 3</xref>, comparativamente entre el examen basal y en la dosis de 20 &#181;g/kg/min.</p>
      <table-wrap id="t3-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt03-es.jpg"/></table-wrap>
      <p><italic>&#149; Seguimiento de los pacientes -</italic> se siguieron a los pacientes por 36,6 &#177; 20,1 meses tras el estr&#233;s con dobutamina. En el seguimiento, se investigaron los eventos de reemplazo valvular a&#243;rtico y muerte cardiaca, y un nuevo Doppler ecocardiograma en condiciones basales se obtuvo. Tres pacientes no retornaron para control. Dos pacientes fallecieron: uno, con regurgitaci&#243;n moderada y aorta dilatada, se muri&#243; de accidente de autom&#243;vil antes que la cirug&#237;a se realizara; el otro paciente, que estaba en clase III para disnea y ten&#237;a angina y s&#237;ncope, muri&#243; a causa de problema valvular. Datos basales, a los 20 &#181;g/kg/min de dobutamina y en el seguimiento de los 20 pacientes en que el Doppler ecocardiograma de control se obtuvo, est&#225;n descritos en la <xref ref-type="table" rid="t4-body3">Tabla 4</xref>.</p>
      <table-wrap id="t4-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gt04-es.jpg"/></table-wrap>
      <p>La FE con la dobutamina se correlacion&#243; con la FE basal (<xref ref-type="fig" rid="f1-body3">Fig. 1</xref>), pero no con la FE en el seguimiento (p = 0,13).</p>
      <fig id="f1-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gf01-es.jpg"/></fig>
      <p>Cinco pacientes se sometieron a cirug&#237;a (dos estaban en clase funcional I y tres en clase funcional III al momento en que la ecocardiograf&#237;a de estr&#233;s se realiz&#243;, con la indicaci&#243;n de la cirug&#237;a realizada por el m&#233;dico asistente). El tiempo promedio para la cirug&#237;a tras el estr&#233;s con dobutamina fue de 11,5 &#177; 5,9 meses. La edad no fue estad&#237;sticamente diferente entre pacientes operados o no (46,6 &#177; 15,5 x 33,8 &#177; 16,5 a&#241;os, p = 0,149). Las FE basales de los pacientes que se operaron estaban entre las m&#225;s bajas del grupo. Tres pacientes mejoraron la clase funcional tras la cirug&#237;a, y dos de los que estaban en clase I permanecieron asintom&#225;ticos en el seguimiento. Aunque tanto los di&#225;metros diast&#243;licos (67,2 &#177; 1,9 &#8594; 50,8 &#177; 1,1; p = 0,043) como los sist&#243;licos (45,6 &#177; 1,5 &#8594; 35,2 &#177; 2,7; p = 0,042) disminuyen con la cirug&#237;a, las FE en el seguimiento de los pacientes operados no fueron estad&#237;sticamente diferentes de sus FE al inicio del estudio (59,3 &#177; 3,3% x 59,4 &#177; 9,5%, p = 0,786).</p>
      <p>El di&#225;metro diast&#243;lico inicial y al seguimiento, en los pacientes que supervivieron sin cirug&#237;a (63,6 &#177; 9,5 y 63,4 &#177; 10,8, respectivamente) no se distingui&#243; (p = 0,636). El mismo ocurri&#243; con los di&#225;metros sist&#243;licos (40,3 &#177; 8,1 y 41,1 &#177; 8,8, respectivamente; p = 0,329) y con la FE (67,0 &#177; 7,3% y 63,9 &#177; 8,1%, respectivamente; p = 0,151).</p>
      <p>En los 20 pacientes en que se obtuvieron los datos ecocardiogr&#225;ficos al seguimiento, la FE inicial era m&#225;s baja en aquellos que tuvieron eventos que en los que supervivieron sin cirug&#237;a (59,3 &#177; 3,3 x 66,0 &#177; 7,9; p = 0,016), como est&#225; detallado en la <xref ref-type="fig" rid="f2-body3">Figura 2</xref>. Sin embargo, el porcentual de aumento de la FE con la dobutamina no result&#243; diferente entre pacientes con eventos y aquellos que supervivieron sin cirug&#237;a, sea con la dosis de 10 &#181;g/kg/min (p = 0,387), de 15 &#181;g/kg/min (p = 0,703) o de 20 &#181;g/kg/min (p = 0,467).</p>
      <fig id="f2-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0053-00010-gf02-es.jpg"/></fig>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El presente estudio revel&#243; correlaci&#243;n de la FE basal con la evoluci&#243;n de los pacientes con regurgitaci&#243;n a&#243;rtica. Sin embargo, la respuesta de la FE a la ecocardiograf&#237;a de estr&#233;s con dobutamina en ese grupo de pacientes no fue eficaz en prever eventos. A causa de la prevalencia a&#250;n alta de enfermedad reum&#225;tica en pa&#237;ses en desarrollo, el grupo de pacientes con regurgitaci&#243;n a&#243;rtica es relativamente joven, comparado a los pacientes con esa patolog&#237;a en pa&#237;ses desarrollados. Por lo tanto, los resultados de este estudio no se pueden aplicar a un grupo con edad m&#225;s avanzada, con regurgitaci&#243;n a&#243;rtica degenerativa.</p>
      <p>Se ha evidenciado en la regurgitaci&#243;n a&#243;rtica que hasta pacientes con FE reducida pueden permanecer asintom&#225;ticos, reflejando el desarrollo insidioso de la disfunci&#243;n ventricular izquierda y la necesidad de frecuentes evaluaciones ventriculares para detectar deterioro adicional antes que una reducci&#243;n importante ocurra, ya que &#233;sta puede tener consecuencias severas, aun tras un reemplazo valvular exitoso<sup>14</sup>. Estudios de la historia natural de la regurgitaci&#243;n a&#243;rtica han enfocado principalmente a pacientes asintom&#225;ticos con funci&#243;n sist&#243;lica normal. Sin embargo, estudios m&#225;s recientes revelan que los resultados sin cirug&#237;a en pacientes, aun con disfunci&#243;n leve (FE &lt; 55% o VIs <underline>&gt;</underline> 25 mm/m<sup>2</sup>) son malos. Esos pacientes, incluso si asintom&#225;ticos al diagn&#243;stico, presentan una mortalidad excesiva a largo plazo si la cirug&#237;a no se realiza<sup>15</sup>. La poscarga excesiva en la regurgitaci&#243;n a&#243;rtica, causada por la combinaci&#243;n de sobrecarga volum&#233;trica y de presi&#243;n, explica en parte la mejora en la funci&#243;n ventricular luego de la reducci&#243;n de la poscarga que ocurre con el reemplazo valvular. As&#237;, la mejora tanto a corto como a largo plazos en la funci&#243;n ventricular despu&#233;s de la cirug&#237;a se relaciona significativamente a la disminuci&#243;n precoz de la dilataci&#243;n ventricular ocasionada por la correcci&#243;n de la sobrecarga volum&#233;trica<sup>3</sup>.</p>
      <p>El aumento de la FE tras el reemplazo valvular en la regurgitaci&#243;n a&#243;rtica est&#225; en contraste con la situaci&#243;n vista en la regurgitaci&#243;n mitral, en la que la FE frecuentemente disminuye despu&#233;s de la cirug&#237;a, incluso si la reparaci&#243;n de la v&#225;lvula se realiza con gran &#233;xito<sup>16,17</sup>. En el presente estudio, no ocurri&#243; aumento en la FE de los pacientes operados, lo que puede sugerir que, aunque estuvieran en clase funcional I (dos pacientes) e II (tres pacientes), y sus FE estuvieran normales o discretamente disminuidas al estudio inicial, ellos probablemente ya ten&#237;an una disminuci&#243;n de la reserva contr&#225;ctil.</p>
      <p>En un estudio de 35 pacientes asintom&#225;ticos con grados 3 y 4 de regurgitaci&#243;n a&#243;rtica que se sometieron a la ecocardiograf&#237;a de esfuerzo, 21 tuvieron aumento de la FE de 7 unidades porcentuales comparado a la FE basal, indicando reserva contr&#225;ctil. Los otros 14 no presentaban reserva contr&#225;ctil. El seguimiento promedio fue de 15 meses; 13 de los 21 con reserva contr&#225;ctil mantuvieron funci&#243;n sist&#243;lica normal, mientras 13 de los 14 sin reserva contr&#225;ctil presentaron una disminuci&#243;n de la FE del 60% para el 54%. En este estudio, la FE basal y la reserva contr&#225;ctil con el ejercicio fueron los &#250;nicos predictores independientes de una disminuci&#243;n de la funci&#243;n sist&#243;lica al seguimento<sup>18</sup>, sugiriendo que el ejercicio sea una forma mejor de investigar esos pacientes de que la ecocardiograf&#237;a de estr&#233;s con dobutamina. No obstante, este es un dato controvertido, ya que hay tambi&#233;n evidencias de que incluso pacientes que presentan disminuci&#243;n de la FE al ejercicio pueden evolucionar bien en el postoperatorio<sup>19,20</sup>, sugiriendo que el descenso de la FE al ejercicio sea multifactorial y se deba analizar con excepciones, ya que puede no deberse necesariamente a la disfunci&#243;n ventricular. Existen pocos estudios en la literatura usando ecocardiograma de estr&#233;s con dobutamina en la regurgitaci&#243;n a&#243;rtica, generalmente implicando un n&#250;mero peque&#241;o de pacientes. En uno de ellos, con 11 pacientes con regurgitaci&#243;n a&#243;rtica y funci&#243;n sist&#243;lica disminuida, la dobutamina provoc&#243; un aumento de la FE basal de 37 &#177; 9 para 43 &#177; 12%, mientras el estr&#233;s sist&#243;lico parietal y la presi&#243;n sist&#243;lica pulmonar no se alteraron. Tres pacientes se sometieron a la cirug&#237;a y se convirtieron asintom&#225;ticos. Un paciente que no aument&#243; la FE con la dobutamina muri&#243;. Los autores concluyen que, en pacientes con regurgitaci&#243;n a&#243;rtica y FE reducida, un aumento de la FE y una reducci&#243;n de los di&#225;metros y vol&#250;menes ventriculares con la dobutamina son variables que indican reserva contr&#225;ctil<sup>11</sup>. Sin embargo, los n&#250;meros fueron muy peque&#241;os para permitir cualquier an&#225;lisis estad&#237;stico.</p>
      <p>De Rito et al.<sup>10</sup>, en otro estudio comparando la ecocardiograf&#237;a de estr&#233;s con dobutamina y la ventriculograf&#237;a de esfuerzo en 26 pacientes con regurgitaci&#243;n a&#243;rtica moderada o severa, constataron concordancia entre esas dos modalidades en la evaluaci&#243;n de pacientes asintom&#225;ticos o m&#237;nimamente sintom&#225;ticos.</p>
      <p>Tam et al.<sup>9</sup> estudiaron a 16 pacientes que se sometieron a la cirug&#237;a electiva para regurgitaci&#243;n a&#243;rtica y que ten&#237;an un ecocardiograma obtenido en condiciones basales y a los 7,5 &#181;g/kg/ min de dobutamina. Esos autores compararon los pacientes que tuvieron recuperaci&#243;n total (normalizaci&#243;n del tama&#241;o y funci&#243;n ventricular en la ausencia de s&#237;ntomas a los seis meses de seguimiento) -grupo I- con aquellos que no se recuperaron completamente -grupo II. La edad, la clase funcional y los di&#225;metros diast&#243;licos finales fueron semejantes entre los grupos. Sin embargo, los pacientes del Grupo I ten&#237;an un &#237;ndice ventricular sist&#243;lico final menor y una FE mayor preoperatorios que los del Grupo II. La dobutamina fue &#250;til en aumentar la diferencia en el tama&#241;o y en la funci&#243;n ventricular de los pacientes de los Grupos I e II. Los autores concluyeron entonces que la FE durante la infusi&#243;n de dobutamina es altamente predictiva de la FE post-operatoria y que esa modalidad de ecocardiograf&#237;a de estr&#233;s puede tener un rol previsi&#243;n de la respuesta cl&#237;nica de pacientes con regurgitaci&#243;n a&#243;rtica que se someter&#225;n al reemplazo a&#243;rtico. Diferentemente de ese estudio, los incrementos porcentuales de la FE a los 10 &#181;g/kg/min, 15 &#181;g/kg/min o 20 &#181;g/kg/ min en el nuestro estudio no fueron capaces de predecir cirug&#237;a o muerte en el seguimiento de los pacientes. Todos los pacientes del estudio de Tam et al.<sup>9</sup> eran candidatos a la cirug&#237;a de reemplazo valvular a&#243;rtico, situaci&#243;n diferente de la observada en nuestros pacientes, que, en la mayor&#237;a, no ten&#237;an indicaci&#243;n quir&#250;rgica. La ecocardiograf&#237;a de estr&#233;s con dobutamina puede haber tenido un desempe&#241;o mejor en la discriminaci&#243;n de pacientes con reserva contr&#225;ctil entre aquellos que ya necesitaban de cirug&#237;a que entre los pacientes asintom&#225;ticos o m&#237;nimamente sintom&#225;ticos. En &#233;stos, el conocimiento de la evoluci&#243;n natural de la enfermedad, la anamnesis bien conducida y los datos de ex&#225;menes como ECG, radiograf&#237;a de t&#243;rax y ecocardiograma transtor&#225;cico con mapeo de flujo en colores parecen ser suficientes, desde que no haya disociaci&#243;n entre ex&#225;menes cl&#237;nicos y complementarios.</p>
      <p>
        <bold>Limitaciones del estudio</bold>
      </p>
      <p>Este es un grupo peque&#241;o de pacientes, sobretodo para analizar eventos en el seguimiento. Estudios implicando un n&#250;mero mayor de pacientes son necesarios para confirmar los hallazgos del presente estudio. Adem&#225;s de ello, nuestro grupo de pacientes era bastante heterog&#233;neo en el que se refiere a la edad, etiolog&#237;a de la enfermedad reum&#225;tica y duraci&#243;n del seguimiento, lo que puede haber influenciado los resultados.</p>
      <p>Tres pacientes fueron perdidos para el seguimiento, y uno falleci&#243; en un accidente de autom&#243;vil. Los resultados podr&#237;an ser diferentes si tuvieran sido obtenidos datos del seguimiento de esos cuatro pacientes.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>Nuestros hallazgos evidenciaron que, en pacientes j&#243;venes con regurgitaci&#243;n a&#243;rtica, la FE basal se correlacion&#243; con cirug&#237;a o muerte en el seguimiento. Sin embargo, el incremento de la FE con infusi&#243;n de baja de dobutamina no fue capaz de predecir eventos en esos pacientes. As&#237; que, con base en esos resultados, la ecocardiograf&#237;a de estr&#233;s con dobutamina no parece ser una herramienta &#250;til en la estratificaci&#243;n de riesgo de pacientes j&#243;venes con regurgitaci&#243;n a&#243;rtica. No obstante, nuevos estudios con n&#250;mero mayor de pacientes y de eventos pueden presentar resultados diferentes.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>No hay vinculaci&#243;n de este estudio a programas de postgrado.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
